✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Kimia Biosciences Ltd.

KIMIABL

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹157 Cr.
P/E
16.37

Kimia Biosciences Ltd.

  • Kimia Biosciences
  • Krebs Biochem.&Inds
  • Coral Laboratories

FAQs on Kimia Biosciences Ltd. Shareprice

Kimia Biosciences has given lower returns compared to its competitors.
Kimia Biosciences has grown at ~-6.79% over the last 3yrs while peers have grown at a median rate of 5.52%

Kimia Biosciences is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Kimia Biosciences is 16.32, while 3 year average PE is 14.13.
Also latest EV/EBITDA of Kimia Biosciences is 0 while 3yr average is 1144.

View FAQ's On Business

Growth Table

  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Coral Laboratories

Balance Sheet

  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Coral Laboratories

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Coral Laboratories

Cash Flow

  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Coral Laboratories

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Coral Laboratories

Quarterly Results

  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Coral Laboratories

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Kimia Biosciences Ltd. Financials

Kimia Biosciences balance sheet is weak and might have solvency issues

The net debt of Kimia Biosciences is decreasing.
Latest net debt of Kimia Biosciences is ₹31.89 Crs as of Mar-25.
This is less than Mar-24 when it was ₹42.48 Crs.

Yes, profit is increasing.
The profit of Kimia Biosciences is ₹8.23 Crs for TTM, -₹5.31 Crs for Mar 2024 and -₹9.35 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kimia Biosciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech